Componenta (CTH1V) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for January–June 2024 were EUR 50.0 million, down 17% from EUR 60.2 million year-over-year.
EBITDA for the period was EUR 1.9 million, a 64.6% decrease from EUR 5.4 million last year.
Operating result was negative at EUR -0.8 million, versus EUR 2.5 million a year earlier.
Q2 showed sequential improvement over Q1, with net sales of EUR 26.4 million and EBITDA of EUR 2.1 million.
Profitability was impacted by weak demand in agricultural machinery, political strikes, and lower raw material and energy indices, but order book and efficiency improved in Q2.
Financial highlights
Cash and cash equivalents at end of June were EUR 6.5 million, compared to EUR 13.0 million last year.
Cash flow from operating activities was EUR 1.8 million, down from EUR 5.4 million year-over-year.
Net interest-bearing debt was EUR 8.9 million, with net gearing at 37.6%.
Equity ratio was 40.3% at period end.
Basic and diluted EPS were EUR -0.20, compared to EUR 0.15 and EUR 0.14 last year.
Outlook and guidance
Guidance for 2024 remains unchanged: net sales and EBITDA expected to improve from 2023, with improvement weighted to the second half.
Order book at end of June was EUR 10.8 million, up from EUR 10.4 million last year.
Volumes and profitability expected to recover in H2 as serial product ramp-up continues and deliveries normalize.
Focus areas include growth, profitability improvement, and integrating new business into heavier production.
A EUR 50 million defense industry contract was announced, expected to benefit results in H2 2024 and beyond.
Latest events from Componenta
- Net sales and profitability surged, with strong cash and order book growth supporting a positive outlook.CTH1V
Q4 20256 Mar 2026 - Sales and EBITDA surged, order book grew, and liquidity stayed stable amid uncertainty.CTH1V
Q3 202530 Oct 2025 - Sales and profit surged, led by energy and defence, with strong cash flow and positive outlook.CTH1V
Q2 202523 Jul 2025 - Net sales and EBITDA fell, but Q3 improved and acquisitions support future growth.CTH1V
Q3 202413 Jun 2025 - Sales and profitability surged, with strong liquidity and a positive outlook for 2025.CTH1V
Q1 20255 Jun 2025 - EBITDA and cash flow surged despite lower net sales, with a strong order book and positive outlook.CTH1V
Q4 20245 Jun 2025